Fig. 3From: URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s diseaseURMC-099 reduces extracellular Aβ40 and Aβ42 levels in the APP/PS1 brain. The levels of Aβ40 (a) and Aβ42 (b) in an extracellular-enriched fraction were measured by human Aβ40- and Aβ42-specific ELISAs. Data are presented as mean ± S.E.M. a,bp < 0.05, a vs APP/PS1 control, b vs APP/PS1/vehicle, one-way ANOVA, and Newman-Keuls post hoc testBack to article page